1. Crowson AN: Basal cell carcinoma: Biology, morphology and clinical implications. Mod Pathol 19(Suppl 2):S127-S147, 2006
2. Roewert-Huber J et al: Epidemiology and aetiology of basal cell carcinoma. Br J Dermatol 157(Suppl 2):47-51, 2007
3. Christenson LJ et al: Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 294:681-690, 2005
4. Levi F et al: Trends in survival for patients diagnosed with cancer in Vaud, Switzerland, between 1974 and 1993. Ann Oncol 11:957-963, 2000
5. Levi F et al: Trends in skin cancer incidence in Vaud: An update, 1976-1998. Eur J Cancer Prev 10:371-373, 2001
6. Stang A et al: Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: A patient- vs. diagnosis-based incidence approach. Int J Dermatol 46:564-570, 2007
7. Kennedy C, Bajdik CD: Descriptive epidemiology of skin cancer on Aruba: 1980-1995. Int J Dermatol 40:169-174, 2001
8. Celic D et al: The incidence of basal cell carcinoma in Croatia: An epidemiological study. Acta Dermatovenerol Croat 17:108-112, 2009
9. Sng J et al: Skin cancer trends among Asians living in Singapore from 1968 to 2006. J Am Acad Dermatol 61:426-132, 2009
10. Gloster HM Jr, Neal K: Skin cancer in skin of color. J Am Acad Dermatol 55:741-760; quiz 61-64, 2006
11. Pelucchi C et al: Risk factors for histological types and anatomic sites of cutaneous basal-cell carcinoma: An italian case-control study. J Invest Dermatol 127:935-944, 2007
12. van Dam RM et al: Risk factors for basal cell carcinoma of the skin in men: Results from the health professionals follow-up study. Am J Epidemiol 150:459-468, 1999
13. Gailani MR et al: Relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma. J Natl Cancer Inst 88:349-354, 1996
14. Benjamin CL, Ananthaswamy HN: p53 and the pathogenesis of skin cancer. Toxicol Appl Pharmacol 224:241-248, 2007
15. Hutchin ME et al: Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: Conditional skin tumorigenesis recapitulates the hair growth cycle. Genes Dev 19:214-223, 2005
16. Adolphe C et al: Patched1 functions as a gatekeeper by promoting cell cycle progression. Cancer Res 66:2081-2088, 2006
17. Epstein EH: Basal cell carcinomas: Attack of the hedgehog. Nat Rev Cancer 8:743-754, 2008
18. Reifenberger J et al: Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol 152:43-51, 2005
19. Lindstrom E et al: PTCH mutations: Distribution and analyses. Hum Mutat 27:215-219, 2006
20. Heitzer E et al: UV fingerprints predominate in the PTCH mutation spectra of basal cell carcinomas independent of clinical phenotype. J Invest Dermatol 127:2872-2881, 2007
21. Situm M et al: The role of UV radiation in the development of basal cell carcinoma. Coll Antropol 32(Suppl 2):167-170, 2008
22. Naldi L et al: Host-related and environmental risk factors for cutaneous basal cell carcinoma: Evidence from an Italian case-control study. J Am Acad Dermatol 42:446-452, 2000
23. Ramani ML, Bennett RG: High prevalence of skin cancer in World War II servicemen stationed in the Pacific theater. J Am Acad Dermatol 28:733-737, 1993
24. Neale RE et al: Basal cell carcinoma on the trunk is associated with excessive sun exposure. J Am Acad Dermatol 56:380-386, 2007
25. Gailani MR et al: The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet 14:78-81, 1996
26. Karagas MR et al: Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group. J Natl Cancer Inst 88:1848-1853, 1996
27. Karagas MR et al: Squamous cell and basal cell carcinoma of the skin in relation to radiation therapy and potential modification of risk by sun exposure. Epidemiology 18:776-784, 2007
28. Berg D, Otley CC: Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol 47:1-17; quiz 8-20, 2002
29. Brewer JD et al: Incidence of and risk factors for skin cancer after heart transplant. Arch Dermatol 145:1391-1396, 2009
30. Carroll RP et al: Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: A prospective study in Queensland, Australia. Am J Kidney Dis 41:676-683, 2003
31. Gorlin RJ: Nevoid basal cell carcinoma syndrome. Dermatol Clin 13:113-125, 1995
32. Goeteyn M et al: The Bazex-Dupre-Christol syndrome. Arch Dermatol 130:337-342, 1994
33. Ashinoff R, Jacobson M, Belsito DV: Rombo syndrome: A second case report and review. J Am Acad Dermatol 28:1011-1014, 1993
34. Bale AE, Gailani MR, Leffell DJ: The Gorlin syndrome gene: A tumor suppressor active in basal cell carcinogenesis and embryonic development. Proc Assoc Am Physicians 107:253-257, 1995
35. Bale AE, Gailani MR, Leffell DJ: Nevoid basal cell carcinoma syndrome. J Invest Dermatol 103:126S-130S, 1994
36. Ramsay HM et al: Multiple basal cell carcinomas in a patient with acute myeloid leukaemia and chronic lymphocytic leukaemia. Clin Exp Dermatol 24:281-282, 1999
37. Cavalier M et al: Skin cancer after nonmyeloablative hematopoietic cell transplantation. Bone Marrow Transplant 37:1103-1108, 2006
38. Harwood CA et al: Clinicopathologic features of skin cancer in organ transplant recipients: A retrospective case-control series. J Am Acad Dermatol 54:290-300, 2006
39. Bastiaens MT et al: Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. J Invest Dermatol 110:880-884, 1998
40. Crum-Cianflone N et al: Cutaneous malignancies among HIV-infected persons. Arch Intern Med 169:1130-1138, 2009
41. Lobo DV et al: Nonmelanoma skin cancers and infection with the human immunodeficiency virus. Arch Dermatol 128:623-627, 1992
42. Oram Y et al: Histologic patterns of basal cell carcinoma based upon patient immunostatus. Dermatol Surg 21:611-614, 1995
43. Gutierrez-Steil C et al: Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L). J Clin Invest 101:33-39, 1998
44. Erb P et al: Role of apoptosis in basal cell and squamous cell carcinoma formation. Immunol Lett 100:68-72, 2005
45. Kaporis HG et al: Human basal cell carcinoma is associated with Foxp3+ T cells in a Th2 dominant microenvironment. J Invest Dermatol 127:2391-2398, 2007
46. Betti R et al: Anatomic location and histopathologic subtype of basal cell carcinomas in adults younger than 40 or 90 and older: Any difference? Dermatol Surg 35:201-206, 2009
47. McCormack CJ, Kelly JW, Dorevitch AP: Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. A possible indicator of differing causes. Arch Dermatol 133:593-596, 1997
48. Raasch BA, Buettner PG, Garbe C: Basal cell carcinoma: Histological classification and body-site distribution. Br J Dermatol 155:401-407, 2006
49. Pinkus H: Epithelial and fibroepithelial tumors. Arch Dermatol 91:24-37, 1965
50. Katona TM et al: Expression of androgen receptor by fibroepithelioma of Pinkus: Evidence supporting classification as a basal cell carcinoma variant? Am J Dermatopathol 29:7-12, 2007
51. Zalaudek I et al: Dermoscopy of fibroepithelioma of pinkus. J Am Acad Dermatol 52:168-169, 2005
52. Miller SJ: Biology of basal cell carcinoma (Part II). J Am Acad Dermatol 24:161-175, 1991
53. Miller SJ: Biology of basal cell carcinoma (Part I). J Am Acad Dermatol 24:1-13, 1991
54. Sherman JE, Talmor M: Slow progression and sequential documentation of a giant basal cell carcinoma of the face. Surgery 130:90-92, 2001
55. Nambi GI et al: Horrifying giant basal cell carcinoma of the face—A case report. J Plast Reconstr Aesthet Surg 61:1248-1249, 2008
56. Fogarty GB, Ainslie J: Recurrent basal cell carcinoma causing spinal cord compression. ANZ J Surg 71:129-131, 2001
57. Kovarik CL, Stewart D, Barnard JJ: Lethal basal cell carcinoma secondary to cerebral invasion. J Am Acad Dermatol 52:149-151, 2005
58. Mathieu D, Fortin D: Intracranial invasion of a basal cell carcinoma of the scalp. Can J Neurol Sci 32:546-548, 2005
59. Soysal HG et al: Basal cell carcinoma of the eyelids and periorbital region in a Turkish population. Ophthal Plast Reconstr Surg 24:201-206, 2008
60. Niazi ZB, Lamberty BG: Perineural infiltration in basal cell carcinomas. Br J Plast Surg 46:156-157, 1993
61. Brown CI, Perry AE: Incidence of perineural invasion in histologically aggressive types of basal cell carcinoma. Am J Dermatopathol 22:123-125, 2000
62. Leibovitch I et al: Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion. J Am Acad Dermatol 53:458-463, 2005
63. Ratner D et al: Perineural spread of basal cell carcinomas treated with Mohs micrographic surgery. Cancer 88:1605-1613, 2000
64. Leibovitch I et al: Orbital invasion by periocular basal cell carcinoma. Ophthalmology 112:717-723, 2005
65. Mikhail GR et al: Metastatic basal cell carcinoma: Review, pathogenesis, and report of two cases. Arch Dermatol 113:1261-1269, 1977
66. Safai B, Good RA: Basal cell carcinoma with metastasis. Review of literature. Arch Pathol Lab Med 101:327-331, 1977
67. Ting PT, Kasper R, Arlette JP: Metastatic basal cell carcinoma: Report of two cases and literature review. J Cutan Med Surg 9:10-15, 2005
68. Pena T et al: Pulmonary metastasis of basal cell carcinoma: A rare manifestation of a common disease with variable clinical course. J Thorac Oncol 4:1026-1027, 2009
69. Elghissassi I et al: Metastatic basal cell carcinoma to the bone and bone marrow. Int J Dermatol 48:481-483, 2009
70. von Domarus H, Stevens PJ: Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 10:1043-1060, 1984
71. Tomas S: Difficult to diagnose skin cancer-the ‘aggressive’ BCC. Aust Fam Physician 38:492-497, 2009
72. Rubin AI, Chen EH, Ratner D: Basal-cell carcinoma. N Engl J Med 353:2262-2269, 2005
73. Scrivener Y, Grosshans E, Cribier B: Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol 147:41-47, 2002
74. Bath-Hextall FJ et al: Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev CD003412, 2007
75. Garcia C, Holman J, Poletti E: Mohs surgery: Commentaries and controversies. Int J Dermatol 44:893-905, 2005
76. Mosterd K et al: Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: A prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol 9:1149-1156, 2008
77. Rowe DE et al: Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: Implications for patient follow-up. J Dermatol Surg Oncol 15:315-328, 1989
78. Rowe DE et al: Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 15:424-431, 1989
79. Leibovitch I et al: Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. J Am Acad Dermatol 53:452-457, 2005
80. Smeets NW et al: Mohs' micrographic surgery for treatment of basal cell carcinoma of the face—Results of a retrospective study and review of the literature. Br J Dermatol 151:141-147, 2004
81. Asgari MM et al: Patient satisfaction after treatment of nonmelanoma skin cancer. Dermatol Surg 35:1041-1049, 2009
82. Ceilley RI, Del Rosso JQ: Current modalities and new advances in the treatment of basal cell carcinoma. Int J Dermatol 45:489-498, 2006
83. Fernandes JD et al: Presence of residual basal cell carcinoma in re-excised specimens is more probable when deep and lateral margins were positive. J Eur Acad Dermatol Venereol 22:704-706, 2008
84. Griffiths RW: Audit of histologically incompletely excised basal cell carcinomas: Recommendations for management by re-excision. Br J Plast Surg 52:24-28, 1999
85. Kumar P et al: Incidence of incomplete excision in surgically treated basal cell carcinoma: A retrospective clinical audit. Br J Plast Surg 53:563-566, 2000
86. Dieu T, Macleod AM: Incomplete excision of basal cell carcinomas: A retrospective audit. ANZ J Surg 72:219-221, 2002
87. Bogdanov-Berezovsky A et al: Risk factors for incomplete excision of basal cell carcinomas. Acta Derm Venereol 84:44-47, 2004
88. Farhi D et al: Incomplete excision of basal cell carcinoma: Rate and associated factors among 362 consecutive cases. Dermatol Surg 33:1207-1214, 2007
89. Wolf DJ, Zitelli JA: Surgical margins for basal cell carcinoma. Arch Dermatol 123:340-344, 1987
90. Huang CC, Boyce SM: Surgical margins of excision for basal cell carcinoma and squamous cell carcinoma. Semin Cutan Med Surg 23:167-173, 2004
91. Johnson TM, Tromovitch TA, Swanson NA: Combined curettage and excision: A treatment method for primary basal cell carcinoma. J Am Acad Dermatol 24:613-617, 1991
92. Chiller K et al: Efficacy of curettage before excision in clearing surgical margins of nonmelanoma skin cancer. Arch Dermatol 136:1327-1332, 2000
93. Alexiades-Armenakas M, Ramsay D, Kopf AW: The appropriateness of curettage and electrodesiccation for the treatment of basal cell carcinomas. Arch Dermatol 136:800, 2000
94. Kopf AW et al: Curettage-electrodesiccation treatment of basal cell carcinomas. Arch Dermatol 113:439-943, 1977
95. Rodriguez-Vigil T, Vazquez-Lopez F, Perez-Oliva N: Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation. J Am Acad Dermatol 56:91-95, 2007
96. Spiller WF, Spiller RF: Treatment of basal cell epithelioma by curettage and electrodesiccation. J Am Acad Dermatol 11:808-814, 1984
97. Thissen MR, Neumann MH, Schouten LJ: A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 135:1177-1183, 1999
98. Kuflik EG, Gage AA: The five-year cure rate achieved by cryosurgery for skin cancer. J Am Acad Dermatol 24:1002-1004, 1991
99. Thissen MR et al: Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck. Dermatol Surg 26:759-764, 2000
100. Oldfield V, Keating GM, Perry CM:
Imiquimod: In superficial basal cell carcinoma.
Am J Clin Dermatol 6:195-200; discussion 1-2, 2005
101. Geisse J et al:
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from two phase III, randomized, vehicle-controlled studies.
J Am Acad Dermatol 50:722-733, 2004
102. Geisse JK et al:
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: A double-blind, randomized, vehicle-controlled study.
J Am Acad Dermatol 47:390-398, 2002
103. Peris K et al:
Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial.
Dermatol Surg 31:318-323, 2005
104. Murphy ME, Brodland DG, Zitelli JA: Definitive surgical treatment of 24 skin cancers not cured by prior
imiquimod therapy: A case series.
Dermatol Surg 34:1258-1263, 2008
105. Love WE, Bernhard JD, Bordeaux JS: Topical
imiquimod or
fluorouracil therapy for basal and squamous cell carcinoma: A systematic review.
Arch Dermatol 145:1431-1438, 2009
106. Epstein E:
Fluorouracil paste treatment of thin basal cell carcinomas.
Arch Dermatol 121:207-213, 1985
107. Gross K, Kircik L, Kricorian G: 5% 5-Fluorouracil cream for the treatment of small superficial Basal cell carcinoma: Efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg 33:433-439; discussion 440, 2007
108. Mattison LK et al: Rapid identification of dihydropyrimidine dehydrogenase deficiency by using a novel 2-13C-uracil breath test. Clin Cancer Res 10:2652-2658, 2004
109. Mattison LK, Johnson MR, Diasio RB: A comparative analysis of translated dihydropyrimidine dehydrogenase cDNA; conservation of functional domains and relevance to genetic polymorphisms. Pharmacogenetics 12:133-144, 2002
110. Johnson MR et al: Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil. Clin Cancer Res 5:2006-2011, 1999
111. Chen JK et al: Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev 16:2743-2748, 2002
112. Taipale J et al: Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 406:1005-1009, 2000
113. Von Hoff DD et al: Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 361:1164-1172, 2009
114. Szpringer E, Lutnicki K, Marciniak A: Photodynamic therapy—Mechanism and employment. Ann Univ Mariae Curie Sklodowska Med 59:498-502, 2004
115. Morrison WH, Garden AS, Ang KK: Radiation therapy for nonmelanoma skin carcinomas. Clin Plast Surg 24:719-729, 1997
116. Basset-Seguin N et al: Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: A 5 year randomized trial. Eur J Dermatol 18:547-553, 2008
117. Marmur ES, Schmults CD, Goldberg DJ: A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg 30:264-271, 2004
118. Szeimies RM et al: A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8–20 mm), with a 12-month follow-up. J Eur Acad Dermatol Venereol 22:1302-1311, 2008
119. Ortiz-Policarpio B, Lui H: Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers. Skin Therapy Lett 14:1-3, 2009
120. Schulte KW et al: Soft x-ray therapy for cutaneous basal cell and squamous cell carcinomas. J Am Acad Dermatol 53:993-1001, 2005
121. Gooding CA, White G, Yatsuhashi M: Significance of marginal extension in excised basal-cell carcinoma. N Engl J Med 273:923-924, 1965
122. Robinson JK, Fisher SG: Recurrent basal cell carcinoma after incomplete resection. Arch Dermatol 136:1318-1324, 2000
123. Dunn M, Morgan MB, Beer TW: Perineural invasion: Identification, significance, and a standardized definition. Dermatol Surg 35:214-221, 2009
124. Jefford M et al: Metastatic basal cell carcinoma: Rapid symptomatic response to
cisplatin and
paclitaxel.
ANZ J Surg 74:704-705, 2004
125. Carneiro BA et al: Metastatic basal cell carcinoma: Complete response to chemotherapy and associated pure red cell aplasia. Cancer Invest 24:396-400, 2006
126. Czarnecki D: The prognosis of patients with basal and squamous cell carcinoma of the skin. Int J Dermatol 37:656-658, 1998
127. Madan V, Lear JT, Szeimies RM: Non-melanoma skin cancer. Lancet 375:673-685